Allspring Global Investments’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.37M | Sell |
132,562
-36,159
| -21% | -$1.46M | 0.01% | 874 |
|
2025
Q1 | $8.67M | Sell |
168,721
-12,401
| -7% | -$637K | 0.02% | 768 |
|
2024
Q4 | $10M | Sell |
181,122
-29,409
| -14% | -$1.63M | 0.02% | 759 |
|
2024
Q3 | $6.92M | Buy |
210,531
+29,465
| +16% | +$969K | 0.01% | 863 |
|
2024
Q2 | $4.92M | Sell |
181,066
-11,237
| -6% | -$305K | 0.01% | 954 |
|
2024
Q1 | $6.99M | Buy |
192,303
+4,889
| +3% | +$178K | 0.01% | 867 |
|
2023
Q4 | $3.8M | Sell |
187,414
-58,558
| -24% | -$1.19M | 0.01% | 1020 |
|
2023
Q3 | $4.37M | Buy |
245,972
+237,445
| +2,785% | +$4.22M | 0.01% | 1005 |
|
2023
Q2 | $154K | Sell |
8,527
-2,005
| -19% | -$36.2K | ﹤0.01% | 1893 |
|
2023
Q1 | $132K | Sell |
10,532
-105
| -1% | -$1.32K | ﹤0.01% | 1933 |
|
2022
Q4 | $156K | Sell |
10,637
-46
| -0.4% | -$674 | ﹤0.01% | 1899 |
|
2022
Q3 | $182K | Sell |
10,683
-1,177
| -10% | -$20.1K | ﹤0.01% | 1850 |
|
2022
Q2 | $173K | Sell |
11,860
-900
| -7% | -$13.1K | ﹤0.01% | 1859 |
|
2022
Q1 | $214K | Sell |
12,760
-125
| -1% | -$2.1K | ﹤0.01% | 2553 |
|
2021
Q4 | $289K | Buy |
+12,885
| New | +$289K | ﹤0.01% | 2526 |
|